John Matthew McDonald

John McDonald practices at Novant Health Presbyterian Medical Center - Unit in Charlotte, North Carolina.

John McDonald's NPI, 1467496869, was assigned on June 15, 2006. John McDonald holds North Carolina license 9801384.

John McDonald's primary practice is Novant Health Presbyterian Medical Center - Unit, at 200 Hawthorne Lane Box 33549, Charlotte, NC 28233 in Mecklenburg County. The practice phone is (704) 384-4000.

John McDonald's primary practice is Novant Health Presbyterian Medical Center - Unit in Charlotte, North Carolina. John McDonald is also affiliated with Novant Health Presbyterian Medical Center. The medical group on file is Novant Health Senior Care - SouthPark. Dmand AI also links John McDonald to 4 more hospitals, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John McDonald practices, 8 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is John McDonald's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has John McDonald's licenses on file in 2 states: North Carolina and Kentucky.

CMS data shows 359 Medicare services from John McDonald across 5 procedure codes in 2024, for 84 Medicare patients. Medicare paid $20,313 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 84 Medicare patients who saw John McDonald in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts John McDonald's median patient age at 69, with 98% women.

In 2024, John McDonald wrote 106 Medicare Part D claims for 40 patients. 86% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $100 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

John McDonald accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists John McDonald as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links John McDonald to 8 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Adenocarcinoma, Clear Cell, Brenner Tumor and Carcinoma, Endometrioid. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 169 general payments to John McDonald from 14 drug and device companies from 2016 to 2024. Honoraria make up the largest share, 31% of the total. TESARO, Inc. paid the most, $40,134.